In addition, in the context of tumor immunity, a couple recent studies have also shown cDC1s to have an essential dual role in enhancing both CD8+ and CD4+ T cell activation and suggested the cDC1 activation of CD8+ T cells can not be separated from the dual role in activating CD4+ T cells (35, 36). This evidence concerns the gene MPPE1 and neoplasm.